GI CONNECT has summarised the highlights of the recent ASCO and WCGIC 2018 meetings for you.
Oncology
GI CONNECT Update from ASCO and WCGIC 2018
Episode 2: Cancers of the upper GI tract
Publication Date
Sep 2021
Dr Joleen Hubbard is Deputy Director of Clinical Research and Academic Affairs for the Allina Health Cancer Institute in Minneapolis, Minnesota. She was previously Assistant Professor of Medical Oncology at Mayo Clinic. She completed medical school and residency at the University of Minnesota and haematology/oncology training at Mayo Clinic, Rochester, Minnesota. Dr Hubbard specialises in the treatment of gastrointestinal cancers, focusing on colorectal cancer. Dr Hubbard is the PI of several phase I clinical trials, investigating novel agents for gastrointestinal cancers. Her research interests also include geriatric oncology with a special interest in clinical and biologic markers of frailty. She serves as a member of the Cancer in the Elderly, as well as the Health Reported Outcomes and Translational Research committees for the North American Alliance of Clinical Trials in Oncology Network.
Assoc. Prof. Joleen Hubbard has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
Advisory boards: Bayer, Merck, BeiGene, Incyte
Research funding to institution: Merck, Boston Biomedical, Treos Bio, Senhwa Pharmaceuticals, Bayer, Incyte, TriOncology, Seattle Genetics, Hutchison MediPharma, Pionyr Immunotherapeutics, Trovogene, G1 Therapeutics, Roche
Programme summary
Duration 5 MIN
Downloadable resources Yes-
Download the slides
-
Language(s)
Other episodes in this series
Episode 1: Lower GI cancer
GI CONNECT Update from ASCO and WCGIC 2018
Episode 2: Cancers of the upper GI tract Current EpisodeShare this programme
Brought to you by
GI CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer, Ipsen, BeiGene Europe and Pierre Fabre.
Meet the experts
Other programmes of interest
Podcast
Oncology
Testing to treatment of BRAF-mutant metastatic NSCLC
Medical experts share their insights on testing and treatment
Experts
Prof. David Planchard, Dr Federico Cappuzzo-
Downloadable
Resources -
23 MIN
-
Nov 2024
Podcast
Oncology
HCC podcast series part 1: The use of IO in unresectable HCC
Medical experts discuss safety and efficacy of IO and IO combinations, clinical trial data, and best practice
Experts
Dr Rachna Shroff, Oncology Brothers (Moderators)Endorsed by
-
Downloadable
Resources -
23 MIN
-
Nov 2024
Video
Oncology
The emerging role of artificial intelligence in precision oncology
Expert opinion on the clinical application of artificial intelligence (AI)
Experts
Prof. Albrecht Stenzinger-
Downloadable
Resources -
6 MIN
-
Nov 2024
Podcast
Oncology
BRAF-mutated CRC: from testing to treatment
Medical experts share insights and review key clinical trials
Experts
Prof. Sebastian Stintzing, Dr Thomas WinderEndorsed by
-
Downloadable
Resources -
25 MIN
-
Nov 2024
Other
Oncology
Biomarker testing in NSCLC: patient and caregiver awareness and understanding
Findings from a global survey presented in a poster at ESMO 2024
Experts
Prof. Christian Rolfo, Prof. Fernando López-Ríos, Dr. Rodrigo Paredes, Amy Moore, Anne-Marie Baird, Shani ShiloEndorsed by
-
Downloadable
Resources -
5 MIN
-
Sep 2024
Podcast
Oncology Rare diseases
Neuroendocrine tumours (NETs) shared decision-making: Exploring the patient journey and individualising treatments
Experts
Dr Mohid S Khan, Sally JenkinsEndorsed by
-
Downloadable
Resources -
23 MIN
-
Sep 2024
